Advanced search
Publication Cover
Nanomedicine Volume 5, 2010 - Issue 1
Submit an article Journal homepage
1,057
Views
3
CrossRef citations to date
0
Altmetric
Review

Surface Activation and Targeting Strategies of Superparamagnetic Iron Oxide Nanoparticles in Cancer-Oriented Diagnosis and Therapy

Meng Meng Lin1 Institute for Science & Technology in Medicine, Keele University, Thornburrow Drive, Hartshill, Stoke-on-Trent, UK.View further author information
,
Hyung-Hwan Kim2 Vascular Medicine Research Unit, Brigham & Women‘s Hospital, Harvard Medical School, Cambridge, MA02139, USA;3 International Research Center of Bioscience & Biotechnology, Jungwon University, KoreaView further author information
,
Hyuck Kim3 International Research Center of Bioscience & Biotechnology, Jungwon University, Korea;4 Faculty of Herb Industry, Jungwon University, KoreaView further author information
,
Jon Dobson1 Institute for Science & Technology in Medicine, Keele University, Thornburrow Drive, Hartshill, Stoke-on-Trent, UK.View further author information
&
Do Kyung Kim1 Institute for Science & Technology in Medicine, Keele University, Thornburrow Drive, Hartshill, Stoke-on-Trent, UK.;3 International Research Center of Bioscience & Biotechnology, Jungwon University, Korea;5 Electrum 229, Isafjordsgatan 22, Royal Institute of Technology (KTH), SE-16 440 Kista, Stockholm, SwedenCorrespondence[email protected]
View further author information
Pages 109-133 | Published online: 21 Dec 2009

Bibliography

  • Pankhurst QA , ConnolyJ, JonesSK, DobsonJ: Applications of magnetic nanoparticles in biomedicine.J. Phys. D.36, R167–R181 (2003).
  • Dobson J : Magnetic nanoparticle-based gene delivery.Gene Deliv.13, 283–287 (2006).
  • Dobson J : Remote control of cellular behaviour with magnetic nanoparticles.Nat. Nanotechnol.3, 139–143 (2008).
  • Kim DK , DobsonJ: Nanomedicine for targeted drug delivery.J. Mater. Chem.19, 6294–6307 (2009).
  • Lin MM , LiS, Kim H-H et al.: Complete separation of magnetic nanoparticles via chemical cleavage of dextran by ethylenediamine for intracellular uptake. J. Mater. Chem. DOI: 10.1039/b918416c (2009) (Epub ahead of print).
  • Binder WH , GlogerD, WeinstablH, AllmaierG, PittenauerE: Telechelic poly(n-isopropylacrylamides) via nitroxide-mediated controlled polymerization and “click” chemistry: livingness and “grafting-from” methodology.Macromolecules40, 3097–3107 (2007).
  • Lattuada M , HattonTA: Functionalization of monodisperse magnetic nanoparticles.Langmuir23, 2158–2168 (2007).
  • Hu F , NeohKG, CenL, Kang E-T: Cellular response to magnetic nanoparticles “PEGylated” via surface-initiated atom transfer radical polymerization. Biomacromolecules7, 809–816 (2006).
  • Fan Q-L , Neoh K-G, Kang E-T, Shuter B, Wang S-C: Solvent-free atom transfer radical polymerization for the preparation of poly(poly(ethylene glycol) monomethacrylate)-grafted Fe3O4 nanoparticles: synthesis, characterization and cellular uptake. Biomaterials28, 5426–5436 (2007).
  • Yoon T-J , Kim JS, Kim BG, Yu KN, Cho M-H, Lee J-K: Multifunctional nanoparticles possessing a “magnetic motor effect” for drug or gene delivery. Angew. Chem. Int. Ed.44, 1068–1071 (2005).
  • Huo QS , MargoleseD, CieslaUet al.: Generalized synthesis of periodic surfactant inorganic composite-materials.Nature368 (6469), 317–321 (1994).
  • Giri S , TrewynBG, StellmakerMP, LinVS: Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles.Angew. Chem. Int. Ed.44, 5038–5044 (2005).
  • Chan WCC , NieSH: Quantum dot bioconjugates for ultrasensitive nonisotopic detection.Science281, 2016–2019 (1998).
  • Xu C , XuK, GuHet al.: Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles.J. Am. Chem. Soc.126, 9938–9939 (2004).
  • Xie J , XuC, XuZet al.: Linking hydrophobic macromolecules to monodisperse magnetite (Fe3O4) nanoparticles via trichloro-s-triazine.Chem. Mater.18, 5401–5403 (2006).
  • De Palma R , PeetersS, Van Bael M et al.: Silane ligand exchange to make hydrophobic superparamagnetic nanoparticles water-dispersible. Chem. Mater.19, 1821–1831 (2007).
  • Hermanson GT : Bioconjugate Techniques (2nd Edition). Hermanson GT (Ed.). Pierce Biotechnology, Thermo Fisher Scietific, Academic Press, NY, USA (2008).
  • Lin W , FritzK, GuerinGet al.: Highly luminescent lead sulfide nanocrystals in organic solvents and water through ligand exchange with poly(acrylic acid).Langmuir24, 8215–8219 (2008).
  • Zhang T , GeJ, HuY, YinY: A general approach for transferring hydrophobic nanocrystals into water.Nano Lett.7, 3203–3207 (2007).
  • Na HB , LeeIS, SeoHet al.: Versatile PEG-derivatized phosphine oxide ligands for water dispersible metal oxide nanocrystals.Chem. Comm.48, 5167–5169 (2007).
  • Qin J , LaurentS, JoYSet al.: A high-performance magnetic resonance imaging T2 contrast agent.Adv. Mater.19, 1874–1878 (2007).
  • Shtykova EV , HuangX, RemmesNet al.: Structure and properties of iron oxide nanoparticles encapsulated by phospholipids with poly(ethylene glycol) tails.J. Phys. Chem.111, 18078–18086 (2007).
  • Xu C , WangB, SunS: Dumbbell-like Au-Fe3O4 nanoparticels for target-specific platin delivery.J. Am. Chem. Soc.131, 4216–4217 (2009).
  • Veiseh O , GunnJW, KievitFMet al.: Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles.Small5, 256–264 (2009).
  • Yang L , MaoH, WangYAet al.: Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.Small5, 235–243 (2009).
  • Narain R , GonzalesM, HoffmanAS, StaytonPS, KrishnanKM: Synthesis of monodispers biotinylated p(NIPAAm)-coated iron oxide magnetic nanoparticles and their bioconjugation to straptavidin.Langmuir23, 6299–6304 (2007).
  • Biju V , MuraleedharanD, NakayamaKet al.: Quantum dot-Insect neuropeptide conjugates for fluorescence imaging, transfection and nucleus targeting of living cells.Langmuir23, 10254–10261 (2007).
  • Yang C , RaitA, PirolloKF, DagataJA, FarkasN, ChangEH: Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo.Nanomedicine4, 318–329 (2008).
  • Choi HS , LiuW, MisraPet al.: Renal clearance of quantum dots.Nat. Biotechnol.25, 1165–1170 (2007).
  • Schipper ML , LyerG, KohALet al.: Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice.Small5, 126–134 (2009).
  • El-Rayes BF , LorussoPM: Targeting the epidermal growth factor receptor.B. J. Cancer91, 418–424 (2004).
  • Yang J , EomK, Lim E-K et al.: In situ detection of live cancer cells by using bioprobes based on Au nanoparticles. Langmuir24, 12112–12115 (2008).
  • Feng B , TomizawaK, MichiueHet al.: Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-his.Biomaterials30, 1746–1755 (2009).
  • Corezzi S , UrbanelliL, CloetensPet al.: Synchrotron-based X-ray fluorescence imaging of human cells labeled with CdSe quantum dots.Anal. Biochem.388, 33–39 (2009).
  • Chen T-J , Cheng T-H, Chen C-Y et al.: Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. J. Biol. Inorg. Chem.14, 253–260 (2009).
  • Loo C , LoweryA, HalasN, WestJ, DrezekR: Immunotargeted nanoshells for integrated cancer imaging and therapy.Nano Lett.5, 709–711 (2005).
  • Eghtedari M , LiopoAV, CoplandJA, OraevskyAA, MotamediM: Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells.Nano Lett.9, 287–292 (2009).
  • Lee S , ChonH, LeeMet al.: Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanoparticles.Biosens. Bioelectron.24, 2260–2263 (2009).
  • Weng KC , NobleCO, Papahadjopoulos-SternbergBet al.: Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo.Nano Lett.8, 2851–2857 (2008).
  • Chen J , WuH, HanD, XieC: Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy for liver cancer.Cancer Lett.231, 169–175 (2006).
  • Wu X , LiuH, LiuJet al.: Immunofluorescent labelling of cancer marker HER2 and other cellular targets with semiconductor quantum dots.Nat. Biotechnol.21, 41–46 (2003).
  • Korpanty G , CarbonJG, GaryburnPA, FlemingJB, BrekkenRA: Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature.Clin. Cancer Res.13, 323–330 (2007).
  • Laakkonen P , AkermanME, BiliranHet al.: Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.Proc. Natl Acad. Sci. USA101, 9381–9386 (2004).
  • Tammela T , ZarkadaG, WallgardEet al.: Blocking VEFR-3 suppresses angiogenic sprouting and vascular network formation.Nature454, 656–660 (2008).
  • Rosenholm JM , MeinanderA, PeuhuEet al.: Targeting of porous hybrid silica nanoparticles to cancer cells.ACS Nano3, 197–206 (2009).
  • Shi X , WangSH, SwansonSDet al.: Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in-vivo magnetic resonance imaging of tumors.Adv. Mater.20, 1671–1678 (2007).
  • Wang SH , ShiX, Van Antwerp M et al.: Dendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cells. Adv. Func. Mater.17, 3043–3050 (2007).
  • Bharali DJ , LuceyDW, JayakumarH, PudavarHE, PrasadPN: Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy.J. Am. Chem. Soc.127, 11364–11371 (2005).
  • Shi X , WangS, MeshinchiSet al.: Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging.Small7, 1245–1252 (2007).
  • Oh J-M , Choi S-J, Lee G-E, Han S-H, Choy J-H: Inorganic drug-delivery nanovehicle conjugated with cancer-cell-specific ligand. Adv. Func. Mater.19, 1617–1624 (2009).
  • Soppimath KS , LiuLH, SeowWYet al.: Multifunctional core/shell nanoparticles self-assembled from pH-induced thermosensitive polymers for targeted intracellular anticancer drug delivery.Adv. Func. Mater.17, 355–362 (2007).
  • Kim D , LeeES, OhKT, GaoZG, BaeYH: Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.Small4, 2043–2050 (2007).
  • Zheng G , ChenJ, LiH, GlicksonJD: Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.Proc. Natl Acad. Sci. USA102, 17757–17762 (2005).
  • Chen J , CorbinIR, LiH, CaoW, GlicksonJD, ZhangG: Ligand conjugation low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo.J. Am. Chem. Soc.129, 5798–5799 (2007).
  • Qian J , LiX, WeiM, GaoX, XuZ, HeS: Bio-molecule-conjugated fluorescent organically modified silica nanoparticles as optical probes for cancer cell imaging.Optics. Expr.16, 19568–19578 (2008).
  • Li J-L , Wang L, Liu X-Y et al.: In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett.274, 319–326 (2009).
  • Freedman M , ChangEH, ZhouQ, PirolloKF: Nanodelivery of MRI contrast agent enhances sensitivity of detection of lung cancer metastases.Acad. Radiol.16, 627–637 (2009).
  • Hu-Lieskovan S , HeidelJD, BartlettDW, DavisME, TricheTJ: Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing‘s sarcoma.Cancer Res.65, 8984–8992 (2005).
  • Abhilash V , BabuS, HeckertEet al.: Protonated nanoparticles surface governing ligand tethering and cellular targeting.ACS Nano3, 1203–1211 (2009).
  • Elfinger A , MauckschC, RudolphC: Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells.Biomaterials28, 3448–3455 (2007).
  • Ortiz-Sanchez E , DanielsTR, HelgueraG, Martinez-MazaO, BonavidaB, PenichetML: Enhanced cytotoxicity of an anti-transferrin receptor IgG3–avidin fusion protein in combination with gambogic acid against human malignant hematopoitetic cells: functional relevance of iron, the receptor, and reactive oxygen species.Leukemia23, 59–70 (2009).
  • Horak D , BabicM, JendelovaPet al.: D-mannose-modified iron oxide nanoparticles for stem cell labelling.Bioconjug. Chem.18, (2007).
  • Brevet D , Gary-BoboM, RaehmLet al.: Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.Chem. Comm.12, 1475–1477 (2009).
  • Arnaout MA , MahalingamB, XiongJP: Integrin structure, allostery, and bidirectional signaling.Annu. Rev. Cell. Dev. Biol.21, 381–410 (2005).
  • Achilefu S , BlochS, MarkiewiczMAet al.: Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression.Proc. Natl Acad. Sci. USA102, 7976–7981 (2005).
  • Lee J-H , Lee K, Moon SH, Lee Y, Park TG, Cheon J: All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew. Chem. Int. Ed.48, 4174–4179 (2009).
  • Peng L , LiuR, MarikJ, WangX, TakadaY, LamKS: Combinational chemistry identifies high-affinity peptidomimetics against a4b1 integrin for in vivo tumor imaging.Nat. Chem. Bio.2, 381–389 (2006).
  • Liu R , PengL, HanH, LamKS: Structure-activity relationship studies of a series of peptidomimetic ligand for α4β1 integrin on Jurkat T-leukemia cells.Biopolymers84, 595–604 (2006).
  • Pitarresi G , CraparoEF, PalumboFS, CarlisiB, GiammonaG: Composite nanoparticles based on hyaluronic acid chemically crosslinked with α, β-polyaspartylhydrazide.Biomacromolecules.8, 1890–1898 (2007).
  • Marha R , ZollerM: CD44 in cancer progression: Adhesion, migration and growth regulation.J. Mol. Histol.35, 211–231 (2004).
  • Dimeo C , PanzaL, CaptitaniDet al.: Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.Biomacromolecules8, 552–559 (2007).
  • Varghese OP , SunW, HilbornJ, OssipovDA: In situ cross-linkable high molecular weight hyaluronan–bisphophonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.J. Am. Chem. Soc.131, 8781–8783 (2009).
  • Kelly K , AlencarH, FunovicsM, MahmoodU, WeisslederR: Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide.Cancer Res.64, 6247–6251 (2004).
  • Garg A , TisdaleAW, HaidariE, KokkoliE: Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.Int. J. Pharm.366, 201–210 (2009).
  • Demirgoz D , GargA, KokkoliE: Pr-b targeted PEGylated liposomes for prostate cancer therapy.Langmuir24, 13518–13524 (2008).
  • Chittasupho C , Xie S-X, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ: ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur. J. Pharm. Sci.37, 141–150 (2009).
  • Veiseh O , SunC, GunnJet al.: Optical and MRI multifunctional nanoprobe for targeting gliomas.Nano Lett.5, 1003–1008 (2005).
  • Veiseh O , KievitFM, GunnJW, RatnerBD, ZhangM: A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.Biomaterials30, 649–657 (2009).
  • Banzato A , RondinaM, Melendez-AlafortLet al.: Biodistribution of a paclitaxel–hyaluronan bioconjugate.Nucl. Med. Biol.36, 525–533 (2009).
  • Krenning EP , BakkerWH, BreemanWAet al.: Localization of endocrine-related tumours with radioiodinated analogue of somatostatin.Lancet1, 242–244 (1989).
  • Kostenich G , LivnahN, BonaseraTAet al.: Targeting small-cell lung cancer with novel fluorescent analogs of somatostatin.Lung Cancer50, 319–328 (2005).
  • Reubi JC : Peptide receptors as molecular targets for cancer diagnosis and therapy.Endo. Rev.24(4), 389–427 (2003).
  • Dasgupta P : Somatostatin analogs: Multiple roles in cellular proliferation, neoplasia, and angiogenesis.Pharm. Therap.102, 61–85 (2004).
  • Kostenich G , Oron-HermanM, KimelS, LivnahN, TsarftyI, OrensteinA: Diagnostic targeting of colon cancer using a novel fluorescent somatostatin conjugate in a mouse xenograft model.Int. J. Cancer122, 2044–2049 (2008).
  • Shen H , HuD, DuJet al.: Paclitaxel–octreotide conjugates in tumor growth inhibition of a459 human non-small cell lung cancer xenografted into nude mice.Eur. J. Pharm.601, 23–29 (2009).
  • Li XB , DuXK, HuoTL, LiuX, ZhangS: Specific targeting of breast tumor by octreotide-conjugated superparamagnetic iron oxide particles using a clinical 3.0-tesla magnetic resonance scanner.Acta Radiol.50, 583–594 (2009).
  • Gozes I : VIP, from gene to behaviour and back: summarizing my 25 years of research.J. Mol. Neurosci.36, 115–124 (2008).
  • Zhang K , AruvaMR, ShanthlyNet al.: Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogs for PET imaging of breast cancer: in vitro/in vivo evaluation.Regul. Pept.144, 91–100 (2007).
  • Onyukel H , JeongJH, RubinsteinI: Nanomicellar paclixatel increases cytotoxicity of multidrug resistant breast cancer cells.Cancer Lett.274, 327–330 (2009).
  • Rubinstein I , SoosI, OnyukelH: Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells.Chem. Biol. Interact.171, 190–194 (2008).
  • Moody TW , ManteySA, FuselierJA, CoyDH, JensenRT: Vasoactive intestinal peptide–camptothecin conjugates inhibit the proliferation of breast cancer cells.Peptides28, 1883–1890 (2007).
  • Dharap SS , WangY, ChandnaPet al.: Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.Proc. Natl Acad. Sci. USA102, 12962–12967 (2005).
  • Zhou J , LeuschnerC, KumarC, HormesJ, SoboyejoWO: A TEM study of functionalized magnetic nanoparticles targeting breast cancer cells.Mater. Sci. Eng. C.26, 1451–1455 (2005).
  • Kim SH , JeongJH, LeeSH, KimSW, ParkTG: LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA–PEG–LHRH conjugate and PEI.Bioconjug. Chem.19, 2156–2162 (2008).
  • Tietze LF , PankninO, MajorF, KrewerB: Synthesis of a novel pentagastrin-drug conjugate for a targeted tumor therapy.Chem. Eur. J.14, 2811–2818 (2008).
  • Ma LX , YuP, VeerendraBet al.: In vitro and in vivo evaluation of Alexa Fluor 680-bombesin [7–14] NH2 peptide conjugate, a high affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.Mol. Imaging6, 171–180 (2007).
  • Liu Z , YanY, LiuS, WangF, ChenX: 18F, 64Cu and 68Ga labeled RGD–bombesin heteropeptides for pet imaging of breast cancer.Bioconjug. Chem.20, 1016–1025 (2009).
  • Huang CM , WeuYT, ChenSY: Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis.Chem. Biol.7, 453–461 (2000).
  • Dagar S , KrishnadasA, RubinsteinI, BlendMJ, OnyukelH: VIP grafted sterically stabilized liposomes or targeted imaging of breast cancer: in vivo studies.J. Control. Release91, 123–133 (2003).
  • Dubuc C , LangloisR, BenardFet al.: Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate.Bioorg. Med. Chem. Lett.18, 2424–2427 (2008).
  • Kim DK , MikhaylovaM, WangFHet al.: Starch-coated superparamagnetic nanoparticles as MR contrast agents.Chem. Mater.15, 4343–4351 (2003).
  • Neuwelt EA , VarallyeyP, BagoAG, MuldoonLL, NesbitG, NixonR: Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.Neuropathol. Appl. Neurobio.30(5), 456–471 (2004).
  • Zhang Y , Zhang Y-F, Bryant J, Charles A, Boado R, Pardridge WM: Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin. Cancer Res.10, 3667–3677 (2004).
  • Vinogradov SV , BatrakovaEV, KabanovV: Nanogels for oligonucleotide delivery to the brain.Bioconjug. Chem.15, 50–60 (2004).
  • Huang R , KeW, LiuY, JiangC, PeiY: The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.Biomaterials29, 238–246 (2008).
  • Peer D , KarpJM, HongS, FarohzardOC, MargalitR, LangerR: Nanocarriers as an emerging platform for cancer therapy.Nat. Nanotechnol.2, 751–760 (2007).
  • Delves PJ , MartinSJ, BurtonDR, RoittIM: Roitt‘s Essential Immunology (11th Edition). Delves PJ, Martin SJ, Burton DR, Roitt IM (Eds). Wiley-Blackwell Blackwell Publishing, MA, USA (2006).
  • Martin AL , LiB, GilliesER: Surface functionalization of nanomaterials with dendritic groups: toward enhanced binding to biological targets.J. Am. Chem. Soc.131, 734–741 (2009).
  • Bjornerud A , JohanssonL: The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system.NMR Biomed.17, 465–477 (2004).
  • Neuberger T , SchopfB, HofmannH, HofmannM, Von Rechenberg B: Superparamagnetic nanoparticle for biomedical applications: possibility and limitations of a new drug delivery system. J. Magn. Magn. Mater.293, 483–496 (2005).
  • De Bondt RB , NelemansPJ, HofmanPAMet al.: Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging.Eur. J. Radiol.64, 266–272 (2007).
  • Gneveckow U , JordanA, ScholzRet al.: Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia.Med. Phys.31(1444–1451), (2004).
  • Ito A , KugaY, HondaHet al.: Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia.Cancer Lett.212, 161–175 (2004).
  • Hilger I , HergtR, KaiserWA: Towards breast cancer treatment by magnetic heating.J. Magn. Magn. Mater.293, 314–319 (2005).
  • Pankhurst QA , ThanhNKT, JoneST, DobsonJ: Progress in applications of magnetic nanoparticles in biomedicine.J. Phys. D.42, 2244001–22416 (2009)
  • Widder KJ , SenyiAE: Magnetic microspheres: a model system for site specific drug delivery in vivo.Proc. Soc. Exp. Biol. Med.58, 141–146 (1978).
  • Senyi AE , WidderKJ, CzerlinskiC: Magnetic guidance of drug carrying microspheres.J. Appl. Phys.49, 3578–3583 (1978).
  • Widder KJ , MorrisRM, PooreGA, HowardDP, SenyiAE: Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin-total remission in yoshida sarcoma-bearing rats.Eur. J. Cancer. Clin. Oncol.19, 135–139 (1983).
  • Alexiou C , ArnoldW, KleinRJet al.: Locoregional cancer treatment with magnetic drug targeting.Cancer Res.60, 6641–6648 (2000).
  • Lemke AJ , Von Pilsach M, Lubbe AS, Bergemann C, Riess H, Felix R: MRI after magnetic drug targeting in patients with advanced solid malignant tumors. Euro. Radiol.14, 1949–1955 (2004).
  • Dobson J : Magnetic nanoparticle-based targeting for drug and gene delivery.Nanomedicine1, 31–37 (2006).
  • Dobson J : Magnetic nanoparticles for drug delivery.Drug Dev. Res.67, 55–60 (2006).
  • Rosengart AJ , KaminskiMD, ChenH, CavinessPI, EbnerAD: Magnetizable implants and functionalized magnetic carriers: a novel approach for noninvasive yet targeted drug delivery.J. Magn. Magn. Mater.293, 633–638 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.